Immunomedics, Inc. News
Stocks Edge Higher, Samsung, Merck, GameStop And Boris Johnson in Focus - Five Things To Know
Stock futures nudge higher after Fed minutes; Samsung posts strongest quarterly profit in four years; Seagen shares jump on report of $40 billion takeover by Merck; GameStop share surge after 4-for-1 stock split plans and Boris Johnson to resign, but seek to stay on as prime minister until autumn.
Dow Futures, Apple, Nikola, FedEx - 5 Things You Must Know Tuesday
Stock futures rise as the Federal Reserve begins a two-day meeting; Apple holds its 'Time Flies' event; the SEC will examine Nikola over a short-seller's fraud claims.
Still Undervalued: Cramer's 'Mad Money' Recap (Monday 9/14/20)
Maybe Merger Mondays are back, says Jim Cramer. News of mergers, acquisitions, investments and earnings show there are still some great deals out there.
Immunomedics, Scientific Games: 5 Top Gainers for Monday
Immunomedics, Scientific Games, Axsome Therapeutics, Seattle Genetics and Vaxart are some of the top gainers for Monday.
Stocks Finish Higher on M&A News and Vaccine Progress
A flurry of mergers and acquisitions news and signs of progress on a coronavirus vaccine boost stocks on Wall Street.
Buy Gilead on Immunomedics Deal? Let's Look at the Charts
Gilead Sciences is up slightly on Monday after announcing an agreement to buy Immunomedics. Here's how the stock is setting up on the charts now.
Gilead Sciences Agrees $21 Billion Takeover Of Cancer Drug Specialist Immunomedics
Gilead said it will pay $88 per share for Immunomedics, a price that values the Morristown, New Jersey-based drugmaker at just over $21 billion.
Dow Futures Gain As AstraZeneca Resumes Coronavirus Vaccine Trials, Tech and Pharma Deals Boost Market Sentiment
Nasdaq futures look set to lead Wall Street higher Monday following the worst week for the tech-focused index since March as sentiment improves amid AstraZeneca's move to re-start its late-stage coronavirus vaccine trial.
TikTok Picks Oracle, Nvidia Buys Arm, Gilead Buys Immunomedics - 5 Things You Must Know Monday
M&A news and progress on a coronavirus vaccine lift stock futures; Oracle is the preferred buyer of TikTok's U.S. operations; Nvidia buys chip designer Arm.
Immunomedics Gets Double-Downgrade to Sell From Goldman Sachs
Immunomedics receives a double downgrade to sell from buy at Goldman Sachs.
Johnson & Johnson Stock Lower After Unveiling End To Global Baby Powder Sales In 2023
Johnson & Johnson, which began selling Baby Powder in 1894, will end all sales of the talc-based product next year.
Apple Stock Edges Higher After Report Indicates iPhone Demand Confidence
Apple is asking assemblers to put together 220 million iPhones this year, Bloomberg reported, a tally that largely matches 2021 levels.
Rivian Stock Higher As 2022 Production Hopes Offset $5.45 Billion Loss Forecast
"The supply chain continues to be the limiting factor in our production rates but we remain confident in our ability to achieve our target," said CFO Claire McDonough.